Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449397A 2,5-dihydro-pyrazolo(3,4-d)pyrimidin-4-ones with an anticonvulsive action and methods for producing the same
10/15/2003CN1449391A N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
10/15/2003CN1449387A Improved methods of synthesis for 9-substituted hypoxanthine derivatives
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449381A New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449283A Compositions for ameliorating attention-deficient/hyperactivity disorder
10/15/2003CN1449280A Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
10/15/2003CN1448184A Injectable pharmaceutical composition containing non-steroid antiphlogistic medicament and method for making same
10/15/2003CN1448182A Product containing eosinophilic,basophilic and high-temp. resistant microbe gene product and use thereof
10/15/2003CN1448181A New use of recombination human nerve growth factor used for preparing medicine of treating drug-induced peripheral nerve desease in carcinosis chemotherapy
10/15/2003CN1448177A Sleepless treating medicine and its preparation
10/15/2003CN1448172A Folium ginkgo injection and preparation thereof
10/15/2003CN1448166A Pure natural infusion for relieving alcoholism and protecting liver and prep. thereof
10/15/2003CN1124281C Somatostatin polypeptide analog and its application
10/15/2003CN1124269C Substituted pryimidine compounds and their use
10/15/2003CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy
10/15/2003CN1124258C Substituted dihydropyridine dicarboxylic ester
10/15/2003CN1124254C Process for preparing optical-purity fluoxetine
10/15/2003CN1124152C Perlingual sweets for relieving acute alcoholism and its preparation method
10/15/2003CN1124150C Headache treating capsule
10/15/2003CN1124140C Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632842 Reducing medication error and enhancing therapeutic compliance of an individual suffering from COPD by providing a single use inhaler
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632824 Have the ability to act at the 5-HT transporter.
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/14/2003US6632813 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
10/14/2003US6632812 Substituted lactams as inhibitors of Aβ protein production
10/14/2003US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632616 A peptide or polypeptide containing tryptophan and a charged amino acid selected from lysine, arganine and histidine and the compound is conjugated to a detactable group, useful to detect an expanded polyglutamine doamine in a sample
10/14/2003US6632449 Compositions and kits comprising a defined boron compound and methods of their preparation
10/14/2003US6632433 Treating cholinergic controlled secretions including excess sweating, lacrimation and mucus secretion to reduce them; smooth muscle disorders; antispasmodic agents; analgesics; cardiovascular arterioles; gastrointestinal disorders
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003US6632427 Adenoviral-vector-mediated gene transfer into medullary motor neurons
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/14/2003CA2082740C Controlled release device
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082918A1 Vegf peptides and their use
10/09/2003WO2003082906A2 Neurotrophic and neuroprotective peptides
10/09/2003WO2003082893A2 Theraputic methods and uses of sapogenins and their derivatives
10/09/2003WO2003082878A1 Substituted amino isoxazoline derivatives and their use as anti-depressants.
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082871A1 Imidazo fused compounds
10/09/2003WO2003082870A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082856A1 Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003WO2003082840A1 κ-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082837A1 Hydroxymorpholinone derivative and medicinal use thereof
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082825A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
10/09/2003WO2003082820A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
10/09/2003WO2003082818A1 Alkaloids compounds, analgesic pharmaceuticals and their preparation
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082806A1 Venlafaxine base
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082347A1 Diagnostic for diseases associated with cerebrospinal fluid circulation failure
10/09/2003WO2003082333A1 Remedy for sleep disturbance
10/09/2003WO2003082332A1 Remedy for glioblastoma
10/09/2003WO2003082331A1 Decoy compositions for treating and preventing brain diseases and disorders
10/09/2003WO2003082329A2 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/09/2003WO2003082320A1 Novel screening method
10/09/2003WO2003082315A1 Remedy for hypermyotonia
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082313A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082309A1 Composition comprising an extract of liriopsis tuber for protecting brain cells and improving memory
10/09/2003WO2003082305A1 Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
10/09/2003WO2003082298A1 Statin therapy for enhancing cognitive maintenance
10/09/2003WO2003082282A1 Method of use
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1833